CHARLOTTE, N.C.--(BUSINESS WIRE)-- Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 third quarter ended March 31, 2024. Third-quarter results: Total net revenue of $342.6 million; growth of 6% over the prior-year period GAAP net loss of $49.2 million, or $(0.36) per fully diluted share, which includes a $140.1 million goodwill, intangible and other long-lived assets impairment related to the company's Contigo Health business Adjusted earnings per share* of $0.55; flat compared to the p...
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association Annual Meeting in San Antonio, TX, May 3 – 6, 2024, showcasing excellent patient experience* with the Prostatic Urethral Lift (PUL) with the UroLift™...
Vivid Seats Delivers Strong First Quarter Results Q1 2024 Marketplace GOV of >$1 Billion (+20% YoY) CHICAGO, May 07, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today provided financial results for the first quarter ended March 31, 2024. “We are proud to deliver another strong quarter, showcasing the power of our core business and the momentum that has continued into 2024,” said...
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results Dosing Completed for Sentinel Cohort of BEACON Phase 1/2 Trial of BEAM-101 in Severe Sickle Cell Disease; Expansion Cohort Initiated Clinical Trial Authorisation (CTA) Application Cleared for the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency; Study to Initiate in First Half of 2024 BEAM-301 On Track for Submission of U.S. Investigational New Drug (IND) Application in First Half of 2024 Ended First Quarter 2024 with $1.1 Billion in Cash, Cash Equivalents and Marketable Securities; Cash Runw...
Radisson Intersects 9.70 g/t Gold Over 4.00 Metres and Adds Second Drill Rig at the O’Brien Gold Project in Quebec ROUYN-NORANDA, Quebec, May 07, 2024 (GLOBE NEWSWIRE) -- Radisson Mining Resources Inc. (TSX-V: RDS, OTCQB: RMRDF) (“Radisson” or the “Company”) is pleased to announce drill results and the acceleration of the ongoing drill program, with the mobilization of a second drill rig, to its 100%-owned O’Brien Gold Project located along the Larder-Lake-Cadillac Break (see and ), halfway between Rouyn-Noranda and Val-d’Or in Quebec, Canada. Highlights: Drill program ...
Radisson recoupe 9,70 g/t en Or sur 4,00 m et mobilise une seconde foreuse au projet aurifère O’Brien au Québec ROUYN-NORANDA, Québec, 07 mai 2024 (GLOBE NEWSWIRE) -- Ressources minières Radisson Inc. (TSX-V : RDS, OTCQB : RMRDF) (« Radisson » ou la « Société ») est heureuse d'annoncer des résultats et l’accélération du programme de forage en cours avec la mobilisation d’une seconde foreuse au projet O'Brien détenu à 100% et localisé le long de la faille Larder-Lake-Cadillac (voir et ), à mi-chemin entre Rouyn-Noranda et Val-d’Or, au Québec, Canada. Faits saillants : Le program...
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma SAN DIEGO, CA and TAICANG, China, May 07, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven researc...
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2024 RBC Capital Markets Healthcare Conference on Wednesday, May 15, 2024, at 11:30 a.m. ET in New York. A live webcast of the fireside chat will be available and in the investors section of the company’s website at . The webcast will be ar...
HOUSTON--(BUSINESS WIRE)-- Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) announced today its results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights – Revenue of $136.9 million, a 13% decrease from $157.5 million in first quarter 2023 driven by declines in wireline completions and ancillary services – High specification rig revenue of $79.7 million, a 3% increase from $77.5 million in first quarter 2023 with additional growth anticipated in future quarters – Net loss of $0.8 million, or negative $0.03 per fully diluted share, a decrease...
SIGNY, Switzerland--(BUSINESS WIRE)-- An accelerating worldwide recovery, compared to 2019 levels In Continental Europe, April 2024 recovery is ahead of Q1 ‘24 recovery, reaching 137%1 in April vs. 128%1 in Q1 ‘24, driven by a strong recovery in Spain (166%1), France (158%1) and Italy (145%1). Regarding origin markets, US shopper recovery accelerated, reaching 336%1 in April vs. 307%1 in Q1 ’24. The shift of the Ramadan period negatively impacted GCC recovery2, which stood at 198%1 in April vs. 277%1 in Q1 ‘24. In Asia Pacific, the recovery rate reached a record level at 194%1 in April v...
A director at Cheil Worldwide Inc bought 2,000 shares at 18,750.000KRW and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
A director at Metemtur Otelcilik Ve Turizm Isletmeleri A.S sold 651,575 shares at 16.483TRY and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors o...
Costamare Inc. Sets the Date for Its First Quarter 2024 Results Release, Conference Call and Webcast Earnings Release: Friday, May 10, 2024, Before Market OpensConference Call and Webcast: Friday, May 10, 2024, at 8:30 a.m. ET MONACO, May 07, 2024 (GLOBE NEWSWIRE) -- Costamare Inc. (NYSE:CMRE), announced today that it will release its results for the first quarter ended March 31, 2024 before the market opens in New York on Friday, May 10, 2024. Conference Call Details: On Friday, May 10, 2024 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the finan...
ECULLY, France--(BUSINESS WIRE)-- Regulatory News: Société déclarante Dénomination sociale SEB S.A (Paris:SK) Adresse du siège social 112 Chemin du Moulin Carron, 69130 Ecully-France Marché réglementé Euronext Paris - Compartiment A ISIN FR0000121709 Nombre d’actions et de droits de vote: 31 Mars 2024 30 avril 2024 Actions composant le capital social (1) 55 337 770 55 337 770 Droits de vote théoriques (2) 81 236 563 81 214 286 Droits de vote exerçables 80 268...
VPG Reports Fiscal 2024 First Quarter Results MALVERN, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, today announced its results for its 2024 first fiscal quarter ended March 30, 2024. First Fiscal Quarter Highlights: Revenues of $80.8 million decreased 9.1% from a year ago.Gross profit margin was 43.4%, as compared to 41.9% reported a year ago.Operating margin was 8.6%, as compared to 11.2% reported a year ago.Adjusted operating margin* was 10.0%, as compared to 11.4% reported a year a...
A director at Metals Acquisition Ltd maiden bought 20,079 shares at 12.450USD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
NNIT A/S: REVENUE GROWTH OF 12.2% AND 5.2% OPERATING MARGIN. FULL-YEAR FINANCIAL OUTLOOK IS MAINTAINED Q1 2024 key highlights The first quarter results were as planned on an overall level. Organic revenue growth of 8.0% driven by Region Denmark and Region Europe partly offset by Region US and Region Asia. The performance of our downscaled Region Asia was impacted by continuing headwind and not as expected. Total revenue growth was 12.2% compared with last year.The group operating profit excluding special items increased from DKK 20m in Q1 2023 to DKK 23.9m in Q1 2024, equal to a group ope...
Within the previous update, the end of March, we mentioned the bullish break above the upper end of the falling trend channel in the weekly chart around the US$85.00/bbl level in the second half of March. This trend change improved the longer-term picture, as the corrective phase of the past two years has ended. This indicates a more sideways market between US$71.50/bbl and US$98.00/bbl in the weekly chart. There remains a bullish undertone as the completed falling wedge pattern in the daily cha...
Bouygues Telecom has reported a solid set of Q1 numbers: SR growth is better at +4.2% y/y from +3.4% y/y, albeit EBITDAaL growth is a little slower at +7.5% y/y from +11.4% y/y in Q4 23. Bouygues and Orange have now both reported, and so we can begin to think about a possible read-across for SFR and Iliad.
Moody's Ratings (Moody's) has affirmed DBS Bank (Taiwan) Ltd's (DBS Taiwan) foreign currency and local currency long-term and short-term deposit ratings at A2/P-1. Moody's has also affirmed the bank's Baseline Credit Assessment (BCA) at baa3 and Adjusted BCA at a2, foreign currency and local curre...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.